Intellectual Property India Publishes Patent Application for 'Immune Compatible Cells For Allogeneic Cell Therapies To Cover Global, Ethnic, Or Disease-Specific Populations' Filed by Garuda Therapeutics, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517043415 A) filed by Garuda Therapeutics, Inc., Cambridge, U.S.A., on May 5, for 'immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations.'

Inventor(s) include Shah, Dhvanit.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "In the various aspects and embodiments, the present disclosure provides cell populations or cell "banks" thereof (e.g., cell collections) to provide immune compatible, allogeneic cell therapies covering global, ethnic, and disease-specific populations. In the various aspects and embodiments, the cell banks and progeny thereof maintain sufficient HLA Class I and HLA Class II functionalities, while facilitating patient matching to prevent or reduce graft versus host disease (GVHD) or graft rejection. The disclosure further provides methods for creating the cell banks by gene editing, and methods for cell therapy involving cells or tissues derived from the cell banks (including but not limited to hematopoietic stem cells, or "HSCs", progenitors, or progenies thereof)."

The patent application was internationally filed on Oct. 05, 2023, under International application No.PCT/US2023/076083.

Disclaimer: Curated by HT Syndication.